Search Results - "Dunn, T. B."

Revisiting Traditional Risk Factors for Rejection and Graft Loss After Kidney Transplantation by Dunn, T. B., Noreen, H., Gillingham, K., Maurer, D., Ozturk, O. G., Pruett, T. L., Bray, R. A., Gebel, H. M., Matas, A. J.

“…Single‐antigen bead (SAB) testing permits reassessment of immunologic risk for kidney transplantation. Traditionally, high panel reactive antibody (PRA),…”
Get full text

A Composite Risk Model for Predicting Technical Failure in Pancreas Transplantation by Finger, E. B., Radosevich, D. M., Dunn, T. B., Chinnakotla, S., Sutherland, D. E. R., Matas, A. J., Pruett, T. L., Kandaswamy, R.

“…Technical failure (TF) continues to have a significant impact on the success of pancreas transplantation. We assessed risk factors for TF in 1115 pancreas…”
Get full text

Proposed Thresholds for Pancreatic Tissue Volume for Safe Intraportal Islet Autotransplantation After Total Pancreatectomy by Wilhelm, J. J., Bellin, M. D., Dunn, T. B., Balamurugan, A. N., Pruett, T. L., Radosevich, D. M., Chinnakotla, S., Schwarzenberg, S. J., Freeman, M. L., Hering, B. J., Sutherland, D. E. R., Beilman, G. J.

“…The simple question of how much tissue volume (TV) is really safe to infuse in total pancreatectomy–islet autotransplantation (TP–IAT) for chronic pancreatitis…”
Get full text

2202 Kidney Transplant Recipients with 10 Years of Graft Function: What Happens Next? by Matas, A. J., Gillingham, K. J., Humar, A., Kandaswamy, R., Sutherland, D. E. R., Payne, W. D., Dunn, T. B., Najarian, J. S.

“…The ultimate goal of clinical transplantation is for the recipients to achieve long‐term survival, with continuing graft function, that is equivalent to that…”
Get full text

Challenges to Research and Innovation to Optimize Deceased Donor Organ Quality and Quantity by Abt, P. L., Marsh, C. L., Dunn, T. B., Hewitt, W. R., Rodrigue, J. R., Ham, J. M., Feng, S.

“…Solid organ transplantation is encumbered by an increasing number of waitlisted patients unrequited by the current organ supply. Preclinical models suggest…”
Get full text

Metabolic Assessment Prior to Total Pancreatectomy and Islet Autotransplant: Utility, Limitations and Potential by Lundberg, R., Beilman, G. J., Dunn, T. B., Pruett, T. L., Chinnakotla, S. C., Radosevich, D. M., Robertson, R. P., Ptacek, P., Balamurugan, A. N., Wilhelm, J. J., Hering, B. J., Sutherland, D. E. R., Moran, A., Bellin, M. D.

“…Islet autotransplant (IAT) may ameliorate postsurgical diabetes following total pancreatectomy (TP), but outcomes are dependent upon islet mass, which is…”
Get full text

Increased Pancreatitis in Allografts Flushed with Histidine‐Tryptophan‐Ketoglutarate Solution: A Cautionary Tale by Alonso, D., Dunn, T. B., Rigley, T., Skorupa, J. Y., Schriner, M. E., Wrenshall, L. E., Stevens, R. B.

“…We reviewed pancreas transplantation outcomes after Histidine‐Tryptophan‐Ketoglutarate (HTK) and University of Wisconsin (UW) preservation solution use between…”
Get full text

Prospective Randomized Trial of Maintenance Immunosuppression With Rapid Discontinuation of Prednisone in Adult Kidney Transplantation by Suszynski, T. M., Gillingham, K. J., Rizzari, M. D., Dunn, T. B., Payne, W. D., Chinnakotla, S., Finger, E. B., Sutherland, D. E. R., Najarian, J. S., Pruett, T. L., Matas, A. J., Kandaswamy, R.

“…Rapid discontinuation of prednisone (RDP) has minimized steroid‐related complications following kidney transplant (KT). This trial compares long‐term (10‐year)…”
Get full text

Comparison of Recipient Outcomes Following Transplant From Local Versus Imported Pancreas Donors by Finger, E. B., Radosevich, D. M., Bland, B. J., Dunn, T. B., Chinnakotla, S., Sutherland, D. E. R., Pruett, T. L., Kandaswamy, R.

“…The shortage of deceased donor organs for solid organ transplantation continues to be an ongoing dilemma. One approach to increase the number of pancreas…”
Get full text

Selective Retransplant After Graft Loss to Nonadherence: Success with a Second Chance by Dunn, T. B., Browne, B. J., Gillingham, K. J., Kandaswamy, R., Humar, A., Payne, W. D., Sutherland, D. E. R., Matas, A. J.

“…Nonadherence (NA) is a difficult posttransplant problem that can lead to graft loss. A retransplant is controversial because of a fear of recurrent NA. We…”
Get full text

Transmission of Anaplastic Large Cell Lymphoma via Organ Donation After Cardiac Death by Harbell, J. W., Dunn, T. B., Fauda, M., John, D. G., Goldenberg, A. S., Teperman, L. W.

“…Recently, donation after cardiac death (DCD) has been encouraged in order to expand the donor pool. We present a case of anaplastic T‐cell lymphoma transmitted…”
Get full text

Quantifying the Risk of Incompatible Kidney Transplantation: A Multicenter Study by Orandi, B. J., Garonzik‐Wang, J. M., Massie, A. B., Zachary, A. A., Montgomery, J. R., Van Arendonk, K. J., Stegall, M. D., Jordan, S. C., Oberholzer, J., Dunn, T. B., Ratner, L. E., Kapur, S., Pelletier, R. P., Roberts, J. P., Melcher, M. L., Singh, P., Sudan, D. L., Posner, M. P., El‐Amm, J. M., Shapiro, R., Cooper, M., Lipkowitz, G. S., Rees, M. A., Marsh, C. L., Sankari, B. R., Gerber, D. A., Nelson, P. W., Wellen, J., Bozorgzadeh, A., Gaber, A. O., Montgomery, R. A., Segev, D. L.

“…Incompatible live donor kidney transplantation (ILDKT) offers a survival advantage over dialysis to patients with anti‐HLA donor‐specific antibody (DSA)…”
Get full text

Kidney Exchange to Overcome Financial Barriers to Kidney Transplantation by Rees, M. A., Dunn, T. B., Kuhr, C. S., Marsh, C. L., Rogers, J., Rees, S. E., Cicero, A., Reece, L. J., Roth, A. E., Ekwenna, O., Fumo, D. E., Krawiec, K. D., Kopke, J. E., Jain, S., Tan, M., Paloyo, S. R.

“…Organ shortage is the major limitation to kidney transplantation in the developed world. Conversely, millions of patients in the developing world with…”
Get full text

Defining the Tipping Point in Surgical Performance for Laparoscopic Donor Nephrectomy Among Transplant Surgery Fellows: A Risk‐Adjusted Cumulative Summation Learning Curve Analysis by Serrano, O. K., Bangdiwala, A. S., Vock, D. M., Berglund, D., Dunn, T. B., Finger, E. B., Pruett, T. L., Matas, A. J., Kandaswamy, R.

“…The United Network for Organ Sharing recommends that fellowship‐trained surgeons participate in 15 laparoscopic donor nephrectomy (LDN) procedures to be…”
Get full text

Unmethylated Insulin DNA Is Elevated After Total Pancreatectomy With Islet Autotransplantation: Assessment of a Novel Beta Cell Marker by Bellin, M. D., Clark, P., Usmani‐Brown, S., Dunn, T. B., Beilman, G. J., Chinnakotla, S., Pruett, T. L., Ptacek, P., Hering, B. J., Wang, Z., Gilmore, T., Wilhelm, J. J., Hodges, J. S., Moran, A., Herold, K. C.

“…Beta cell death may occur both after islet isolation and during infusion back into recipients undergoing total pancreatectomy with islet autotransplantation…”
Get full text

HLA‐A, ‐B, ‐C, ‐DR, and ‐DQ Matching in Pancreas Transplantation: Effect on Graft Rejection and Survival by Rudolph, E. N., Dunn, T. B., Mauer, D., Noreen, H., Sutherland, D. E. R., Kandaswamy, R., Finger, E. B.

“…To enhance selection of appropriate deceased donors for pancreas transplants, we sought to determine whether HLA matching improved posttransplantation…”
Get full text

Anti-CD25 Antibody (Daclizumab) Maintenance Therapy in Pancreas Transplantation by Kirchner, V.A, Suszynski, T.M, Radosevich, D.M, Humar, A, Dunn, T.B, Hill, M.J, Finger, E.B, Sutherland, D.E.R, Kandaswamy, R

“…Abstract Background Calcineurin inhibitors (CNI) are the basis of contemporary immunosuppression in clinical pancreas transplantation (PT). Nevertheless, CNI…”
Get full text

Global kidney exchange: Financially incompatible pairs are not transplantable compatible pairs by Rees, M. A., Paloyo, S. R., Roth, A. E., Krawiec, K. D., Ekwenna, O., Marsh, C. L., Wenig, A. J., Dunn, T. B.

Get full text

The prognostic significance of glutamic acid decarboxylase antibodies in patients with chronic pancreatitis undergoing total pancreatectomy with islet autotransplantation by Kizilgul, M., Wilhelm, J.J., Dunn, T.B., Beilman, G.J., Pruett, T.L., Chinnakotla, S., Amin, K., Hering, B.J., Bellin, M.D.

“…Islet autotransplantation (IAT) is considered a ‘non-immune’ model of islet transplant, with no risk for autoimmune-mediated beta cell loss, but we have…”
Get full text

Sitagliptin Treatment After Total Pancreatectomy With Islet Autotransplantation: A Randomized, Placebo‐Controlled Study by Bellin, M. D., Beilman, G. J., Dunn, T. B., Pruett, T. L., Sutherland, D. E. R., Chinnakotla, S., Hodges, J. S., Lane, A., Ptacek, P., Berry, K. L., Hering, B. J., Moran, A.

“…Insulin independence after total pancreatectomy and islet autotransplant (TPIAT) for chronic pancreatitis is limited by a high rate of postprocedure beta cell…”
Get full text